Recurrent C. Diff

C. Difficile or Clostridioides difficile
CDIFF According to the CDC

---

Clostridioides difficile (also known as C. diff or CDIFF) is a bacterium that causes diarrhea and colitis (an inflammation of the colon).

It’s estimated to cause almost half a million illnesses in the United States each year.

About 1 in 6 patients who get C. diff will get it again in the subsequent 2-8 weeks.

Within a month of diagnosis, 1 in 11 people over age 65 died of a healthcare-associated C. diff infection.

PRISM-EXT: An Open-Label Extension of CP101 Trial Evaluating Oral FullSpectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection

Watch the recurrent C. Diff testimonial below.

---

https://vimeo.com/382604645

Contact Research

Physician Investigator

Bharat K Misra, MD

Gastroenterologist and Research Director Encore Borland Groover Clinical Research (EBGCR)

4800 Belfort Road Jacksonville FL 32256 postal Contact Research: 9046800871 Research Email: BMisra@encoredocs.comINTERNET

---

NASH is closely related to the triple epidemic of obesity, pre-diabetes, and diabetes.  If you are living with NASH you may qualify for a clinical research study.

MASH is the advanced stage of MASLD. MAFLD is a type of metabolic syndrome characterized by being overweight or obese, elevated blood pressure, blood lipids, and either diabetes or pre-diabetes. Researchers believe that oxidative stress, inflammatory proteins, liver cell damage, adipose tissue inflammation, and the gut microbiota may contribute to its development.

Join Encore Borland Groover Clinical Research (EBGCR) for a complimentary Fibroscan test for fatty liver. 

ClinicalTrials.gov Study Details

Contact Research